REMABIRAT

Film-coated tablet, 250mg
RxActive license

Active substance (INN)

abiraterone

Pharmaceutical form

Pharmaceutical formFilm-coated tablet
Strength250mg
PackagingUkupno 120 film tableta u blisteru djeljivom na pojedinačne doze (12x(10x1)) u kartonskoj kutiji
ManufacturerRemedica Ltd., Cyprus
Therapeutic groupAntineoplastic and immunomodulating agents (L02BX03)
Marketing authorization holderDRUŠTVO ZA TRGOVINU, PROMET I USLUGE "PONTERA PHARMA SOLUTIONS" DOO PODGORICA
Authorization dateFebruary 11, 2026

Analogs in Montenegro

8

Other medicines with the same active substance

ABESINERx
Film-coated tablet, 250mgPharmadox Healthcare Ltd.
Abirateron EGRestricted
Film-coated tablet, 500mgStada Arzneimittel AG
ABIRATERON TEVARx
Film-coated tablet, 500mgBalkanpharma Dupnitsa AD
ENAGALRx
Film-coated tablet, 500mgRemedica Ltd.
ENAGALRx
Film-coated tablet, 250mgRemedica Ltd.
JONOSOLRestricted
Film-coated tablet, 250mgStada Arzneimittel AG
REMABIRATRx
Film-coated tablet, 500mgRemedica Ltd.
ZYTIGARx
Tablet, 250mgJanssen Cilag S.p.A.
Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026